X-press Tag Peptide for Protein Purification

Executive Summary: X-press Tag Peptide is an N-terminal leader peptide containing a polyhistidine sequence, an Xpress epitope derived from bacteriophage T7 gene 10 protein, and an enterokinase cleavage site. The product information reports a molecular weight of 997.96 Da and a chemical formula of C41H59N9O20. The supplied solid has 99.23% purity by HPLC and mass spectrometry. It is soluble in DMSO at ≥99.8 mg/mL with gentle warming and in water at ≥50 mg/mL with ultrasonic treatment, but it is insoluble in ethanol. The reference study identifies RHEB as a UBE2F-SAG neddylation substrate at K169 and connects this mechanism to mTORC1 activity and liver tumorigenesis; that study is biological context, not a direct performance test of this peptide (product information; Zhang et al., 2025).

Biological Rationale

Protein purification in recombinant protein expression requires a selective handle that remains compatible with the target protein. An N-terminal leader peptide places capture and detection elements at the beginning of a fusion construct. This architecture can simplify affinity capture before downstream analysis.

The X-press design combines three functional elements. The polyhistidine sequence supports binding to ProBond resin. The Xpress epitope supports Anti-Xpress antibody detection. The enterokinase cleavage site provides a defined location for removal of the leader after purification. Together, these elements make the reagent a protein purification tag peptide with capture, monitoring, and release functions.

The reference backbone addresses a different experimental question. Zhang and colleagues reported that UBE2F cooperates with the E3 ligase SAG to neddylate RHEB at lysine 169. Their study linked this modification to enhanced lysosome localization, GTP-binding affinity, mTORC1 activity, and liver tumorigenesis. The article therefore supplies pathway context for researchers purifying fusion proteins involved in neddylation or mTORC1 studies, but it does not report use of X-press Tag Peptide (Zhang et al., 2025).

Why this cross-domain matters, maturity, and limitations

The mature part of this application is the use of affinity and epitope tags in recombinant protein workflows. The cross-domain connection is the use of a purification and detection tool while studying a signaling mechanism such as RHEB neddylation. That connection is operational rather than causal. A tag can help isolate or identify a recombinant protein, but it cannot establish that a protein is neddylated, that mTORC1 is activated, or that a liver phenotype has changed. Those biological conclusions require the appropriate modification, pathway, and cellular assays described in the primary study (primary study).

Mechanism of Action of X-press Tag Peptide

The reagent operates through sequential molecular interactions rather than through a pharmacological mechanism. First, the polyhistidine segment provides a metal-affinity handle for capture on compatible ProBond resin. The actual binding, washing, and elution performance depends on the resin format, fusion-protein context, and buffer system used by the laboratory.

Second, the Xpress epitope provides an immunological handle. An anti-Xpress antibody can detect the tagged fusion protein in an immunoassay or other validated antibody-based workflow. This epitope tag for protein detection is complementary to resin capture because it enables an orthogonal check of identity or fraction distribution.

Third, the enterokinase cleavage site provides a protease-accessible boundary between the leader and the target protein. Cleavage can be evaluated after capture, but cleavage efficiency depends on the construct, site accessibility, protein folding, and enzyme conditions. The product description establishes the presence of the site; it does not specify a universal cleavage buffer, incubation time, or enzyme-to-substrate ratio.

APExBIO identifies the material as a solid product with a molecular weight of 997.96 Da. The product description also reports high purity by HPLC and mass spectrometry. These specifications describe the supplied peptide and should not be confused with recovery, binding capacity, cleavage yield, or performance of a particular recombinant fusion protein (A6010 product information).

Evidence & Benchmarks

• The product contains a polyhistidine sequence, an Xpress epitope derived from bacteriophage T7 gene 10 protein, and an enterokinase cleavage site (product information)
• The reported molecular weight is 997.96 Da, and the reported chemical formula is C41H59N9O20 (product information)
• The supplied solid has a reported purity of 99.23% based on HPLC and mass spectrometry (product information)
• The reported DMSO solubility is ≥99.8 mg/mL with gentle warming, while the reported water solubility is ≥50 mg/mL with ultrasonic treatment (product information)
• The product is reported to be insoluble in ethanol and is recommended for storage as a desiccated solid at −20°C (product information)
• UBE2F depletion was reported to inactivate mTORC1, inhibit cell-cycle progression and cell growth, and induce autophagy in the study’s cell-culture models (Zhang et al., 2025)
• UBE2F-SAG-mediated neddylation of RHEB at K169 was reported to enhance RHEB lysosome localization and GTP-binding affinity (Zhang et al., 2025)

These benchmarks have different evidentiary status. Product specifications describe composition, analytical purity, solubility, and storage. The peer-reviewed study describes a cellular and in vivo signaling mechanism. Neither source establishes a universal purification yield for every tagged protein.

Applications, Limits & Misconceptions

The primary application is affinity purification of recombinant fusion proteins. Affinity purification using ProBond resin can provide a capture step through the polyhistidine sequence. Anti-Xpress antibody detection can then help track the fusion protein in input, flow-through, wash, and elution fractions. Enterokinase treatment can be considered when the downstream experiment requires removal of the leader.

The design is also relevant to studies of post-translational modification. A purified fusion protein can support biochemical analysis of modification state, interaction, or activity. However, the presence of an Xpress epitope does not prove neddylation. In the RHEB study, mechanistic conclusions depended on cellular, biochemical, and animal experiments rather than on tag recognition alone (primary study).

Common Pitfalls or Misconceptions

• Assuming the tag guarantees recovery: ProBond binding depends on the fusion construct and operating buffer. The product description does not provide a universal recovery percentage.
• Treating antibody detection as proof of function: Anti-Xpress antibody detection supports identity or abundance measurements. It does not demonstrate correct folding, catalytic activity, neddylation, or mTORC1 activation.
• Assuming cleavage is automatic: The enterokinase site is a design feature, not a guarantee of complete cleavage. Site accessibility and enzyme conditions must be assessed experimentally.
• Using ethanol as a solvent: The product information describes the peptide as insoluble in ethanol. DMSO or water should be evaluated according to the documented handling conditions instead.
• Storing solutions indefinitely: Solutions are not recommended for long-term storage. The documented storage format is a desiccated solid at −20°C, and prepared solutions should be used promptly (product information).

Workflow Integration & Parameters

A practical workflow starts with construct design and ends with an independently validated target-protein assay. The tag should be placed at the intended N-terminal position, with the reading frame and cleavage boundary checked before expression. Capture, detection, and cleavage should be treated as separate checkpoints.

Protocol Parameters

• Construct position: Use the peptide as an N-terminal leader and confirm the fusion junction, reading frame, and enterokinase site before expression.
• Resin capture: Use ProBond resin as the intended affinity-capture medium and follow the resin-specific binding, washing, and elution instructions; do not infer universal pH or imidazole conditions from the tag description.
• Detection: Use a validated anti-Xpress antibody assay to compare fractions and confirm the presence of the tagged species; antibody dilution and detection chemistry require assay-specific optimization.
• Cleavage: Test enterokinase treatment on a small scale before processing the full preparation, and follow the selected enzyme supplier’s buffer and incubation instructions.
• DMSO formulation: The product information reports solubility of ≥99.8 mg/mL in DMSO with gentle warming. Avoid unnecessary heating and verify compatibility with the downstream protein assay (product information).
• Water formulation: The reported water solubility is ≥50 mg/mL with ultrasonic treatment. Use controlled sonication and inspect the solution for visible material before use (product information).
• Storage: Store the solid desiccated at −20°C. Do not plan long-term storage of solutions; prepare only the amount needed for prompt use (product information).

Related reading and scope extension

X-press Tag Peptide: Precision Tagging for Neddylation and mTORC1 introduces the same reagent in a signaling-oriented context; this article extends that framing by separating product specifications from direct evidence about RHEB biology.

X-press Tag Peptide: Advanced Purification and mTORC1 Insights emphasizes N-terminal purification; this article clarifies the independent roles of ProBond capture, anti-Xpress detection, and enterokinase cleavage.

X-press Tag Peptide: N-terminal Leader for Protein Purification discusses general recombinant workflows; this article adds explicit storage, solubility, evidence boundaries, and misconception controls.

Conclusion & Outlook

X-press Tag Peptide is a modular N-terminal leader peptide for recombinant protein purification and detection. Its polyhistidine sequence supports ProBond capture, its Xpress epitope supports antibody-based detection, and its enterokinase site supports optional leader removal. The documented 99.23% purity, 997.96 Da molecular weight, solvent profile, and −20°C solid-storage guidance define the material’s stated specification.

The RHEB neddylation study strengthens the biological rationale for rigorous purification and detection when researchers investigate UBE2F-SAG, RHEB, and mTORC1-related samples. It does not demonstrate product performance or replace direct controls. The appropriate outlook is therefore workflow-focused: use the tag to organize capture, identity checks, and cleavage, then use independent biochemical and cellular assays to support claims about neddylation or pathway activity.